Covishield

Covid Vaccine: Bharat Biotech Gets DCGI Permission For Intranasal Booster Dose Trials

Covishield, Covaxin Granted Regular Market Approval For Use In Adult Population

Prices Of Covishield, Covaxin Likely To Be Capped At Rs 275 After Regular Market Approval

Govt Panel Recommends Regular Market Approval For Covishield And Covaxin

Uttar Pradesh schools, colleges closed till January 23 due to spike in COVID-19 cases

ABP News Impact | EC extends ban on roadshows, rallies till January 22

India’s Covid vaccination drive completes 1 year, know the challenges healthcare workers faced

India’s Covid-19 vaccination drive completes 1 year, over 157 crore vaccine doses given so far

COVID norms go for a toss at Jallikattu event, thousands of lives at stake | Sansani (15 Jan 2022)

Coronavirus cases in India: EC likely to make decision on ban on election rallies amid rising cases

India logs over 2 Lakh Covid cases for third day in a row

Jallikattu events begin in Tamil Nadu, flouting of COVID-19 norms is rampant